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Abstract  
Background: Oral Lichen Planus is a common chronic mucocutaneous disease 
of unknown etiology.  It affects up to 3% of females, is four times less frequent 
in males and is diagnosed predominantly after the age of 40.  
Aim: The goal of this study was to investigate whether ApoE was upregulated in 
OLP and whether increased ApoE could differentiate human monocytic cell 
lines to dendritic cells. 
Method: Gene expression from two patients diagnosed with OLP was analyzed 
using microarray.  Selected genes were then analyzed using RT-PCR to confirm 
the results. Multicolor immunohistofluoresence staning for ApoE expressing 
macrophages were performed on cryosections from on OLP lesions. Two 
human monocytic cell lines (U937, THP-1) was incubated with a humanized 
version of previously reported self peptide (Ep1.B) derived from murine ApoE 
to  test for dendritic cell maturation. 
Results:  Microarray based expression studies revealed that mRNA for  ApoE 
was 8-14 times more expressed in diseased OLP lesions compared to less 
diseased areas from the same patient.  RT-PCR for ApoE and CD3 revealed that 
the ApoE gene expression level correlated to T cell infiltration (CD3delta) and 
thus to the inflammation. Immunohistochemistry did not reveale any strong 
macrophage specific ApoE expression, in contrast to CD68+ macrophages in the 
tonsils. Stimulation of the human monocyte cell lines with a humanized version 
of the ApoE derived self peptide revealed a strong protein agglutinating 
propertiy of the peptide, making cellular analysis almost impossible. However, 
the humanized self-peptide induced, apparently an increased translocation of 
CD205 ( DEC-205) from cytoplasma to the cellular membrane. Thus, a the 
selfpeptide may induce monocytes to become more functional dendritic cells, 
but further analysis could not be performed due to the peptides ability to 
agglutinate both cells and serum proteins in the culture media. 
Conclusion:  Although murine ApoE may play a role in immune regulation, 
there is as of now no evidence to support a conclusion that human ApoE play a 
key role in the complex immunopathology of oral lichen planus. 
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Introduction – subject selection and motivation 
Oral Lichen Planus (OLP) is a common chronic bilateral mucocutaneous disease 
of unknown etiology.  It affects up to 3% of females, is four times less frequent 
in males, is diagnosed predominantly after the age of 40 and may present itself 
as one of six clinically defined forms (8).  
Reticular OLP is the most common form. The typical lesion is on the buccal 
surface which is covered with numerous interlacing white keratotic lines or 
striae (Wickhams striae). This form is usually asymptomatic and discovered 
during routine examination. Reticular form is often present alongside the other 
clinical OLP forms (25) 
 
Erosive OLP shows a painful central ulceration with a pseudo membrane 
covering the ulceration.  It is the second most common clinical presentation after 
reticular form (25) 
 
Figure 1: Reticular OLP on 
buccal mucosa. Note the erosive 
lesion in the center.              
Picture taken from 
www.cixip.comindex.phppagecon
tentid1033) 
Figure 2: Erosive lichen planus 
on the tongue. Picture taken from 
oral-lichen-planus.blogspot.no 
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Plaque OLP resembles leukoplakia, but has a multifocal distribution, usually on 
dorsum of the tongue or on the buccal mucosa (25) 
 
 
Erythematous/atrophic OLP present itself as red patches with very fine white 
striae, usually on attached gingiva. Patients complain of burning, sensitivity and 
general discomfort. This form may resemble cicatrisiell pemfigoid (25). 
 
 
 
 
The Bullous OLP variant has short lived bullae, which leaves a painful ulceration 
when rapturing (25). 
Figure 3: Plaque form on the 
lateral border of the tongue. 
Picture taken from 
www.dentalcare.com 
Figure 4: Erythematous/atrophic 
lichen planus on attached gingiva. 
Picture taken from 
www.dentalcare.com 
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Although reticular and erosive OLP’s are the most common variants, they often 
coexist together with the other subtypes.  
Treatment of OLP can be a challenge. Asymptomatic lesions can usually be 
observed without any treatment. However, around 70% of OLP patients report 
symptoms from the lesions (2). For these patients, active treatment such as 
locally and systemic corticosteroids, as well as surgical intervention may be 
considered. As many as 20-60% of  OLP patients may have additional cutaneous 
lesions  (25).  
Figure 5: Bullous oral lichen planus on buccal mucosa (arrow). Bullae 
normally rupture quickly and leave a erosive like wound. Picture taken from 
screening.iarc.fratlasora. 
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Figure 6:  Flow charts showing the clinical follow up of patients with OLP (26). Follow-up 
interval at least every 6 months with dentist or oral surgeon. Cancer suspect lesions are 
referred immediately to specialist. Treatment with steroids is the first choice in patients with 
symptomatic lesions. Preferably administered locally, but systemic use is considered with lack 
of clinical effect. OLP lesions are often infected with candida species and for this reason 
antifungal treatment should always be considered as a supplement. Tacrolimus (FK-506 or 
fujimycin) is a macrolide class immunosuppressive drug commonly used in treatment of 
allogeneic organ transplant. It is an alternative to steroid treatment when contraindications for 
this treatment are present.  Retinoids are a class of drugs chemically related to vitamin A. It 
has immunosuppressive properties and as such it can be an alternative the in treatment of 
OLP. 
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OLP is histologically characterized by an intense sub epithelial T lymphocyte 
infiltration and disruption of the basal membrane. The pronounced apoptosis of 
basal keratinocytes may be caused by CD8+ cytotoxic T-cells (3), resembling a 
hypersensitivity reaction. 
 
Figure 7:  Histological picture of OLP. Hyperkeratosis and saw tooth shaped epithelium with 
intense lymphocyte infiltration underneath the basal lamina.  
 
Eosinophilic colloid bodies along the epithelial-connective tissue interface 
(Civatte bodies) are frequently found. The inter papillary ridges may either be 
absent, hyperplastic or saw tooth-shaped.  The thickness of the spinous layer 
varies. OLP lesions display various degrees of ortho or parakeratosis (18). 
  
Figure 8: Civic bodies (CB) in an OLP lesion 
(http://www.flickr.com/photos/asnaan1/4159937756/sizes/m/in/photostream/) 
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OLP is usually not considered lethal disease, but it may be difficult to 
distinguish from more serious conditions, such as leukoplakia and squamous cell 
carcinoma. However, the risk of malignant transformation is less than 2% (8).  
OLP may sometimes exacerbate in periods of psychological stress and anxiety, 
which may hint to dysregulation of the immune system (3). 
 
There have been speculations that both bacterial and viral infections, 
autoimmunity, immunodeficiency, food allergies, stress, habits, trauma, diabetes 
and hypertension, malignant neoplasms and bowel diseases may increase the 
risk of OLP, but no definite proof has yet been put forward (26). 
 
Of the different etiological theories, there is much debate about the autoimmune 
nature of OLP. Thus, an antigen-specific cell mediated immune response 
directed to a yet unknown, epithelial antigen(s). Some of the histological feature 
of OLP is similar to a chronic host versus graft disease. Presentation of antigens 
by basement layer keratinocytes may therefore induce cytotoxic T lymphocyte 
(CD8+) to kill these basal cells (18). Such reaction would be HLA-class-I 
dependent, whereas antigen presentation in HLA-class-II may be mediated by 
intraepithelial Langerhans cells (LCs) or directly by keratinocytes, both of 
which have increased HLA-DR expression in the lesion, presumably due to 
cytokines produced by the subepithelial lymphocyte infiltrate (26). As in all 
inflammatory reactions, there are increased expression of adhesion molecules 
such as ELAM-1, ICAM-1 and VCAM-1 to mediate lymphocyte homing to the 
OLP lesion, which may explain the massive subepithelial infiltrate in OLP and 
the presence of hepatitis C specific T cells in the infiltrate without any evidence 
for active hepatitis C production in the lesion. 
 
There has been some speculation that the primary defect in OLP is the 
disruption of the basement membrane. Some of the T cells may be drawn to the 
lesion by the pre-existing inflammation in OLP. These non specific mechanisms 
may activate the innate immune system, activate metalloproteinase which 
disrupt the epithelial basement membrane, induce apoptosis of basal 
keratinocytes allowing non-specific T cells to migrate into the epithelium and to 
set up a chronic inflammatory reaction (25). Matrix metalloproteinase, 
chemokine’s and mast cells all contribute to the increased degree of 
inflammation and may participate in the chronicity of the disease (26). 
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OLP has long been suspected to be an autoimmune disease and many theories 
have been proposed to compensate for the lack of evidence. 
 
1) Lower expression of TGF-B1 has been found in OLP. TGF-B1 has 
immunosuppressive effects. This may predispose for the condition and 
also play a part in the chronicity. 
 
2) Normal oral mucosa is considered an immune privileged site. A 
breakdown of this may contribute to the disease. In particular the balance 
between keratinocyte apoptosis triggered by infiltrating T cells and T cell 
apoptosis triggered by resident keratinocytes. Failure in the latter 
mechanism may cause excessive T cell infiltration in epithelium (26). 
 
3) Dendritic cells and LCs mature in OLP in response to inflammatory 
cytokines (IL-1B, TNF-Alfa), CD40L (CD154) expressed on activated T-
cells, necrotic cells, heat shock proteins, nucleotides among others (26). 
 
4) Heat shock proteins are up regulated in OLP. Possibly by drugs, 
infections, bacterial products and trauma. This may cause T cells to 
proliferate (26). 
 
 
Epidemiological evidences suggest that chronic Hepatitis C Virus (HCV) 
infection may be an etiologic factor in OLP. Although, this association is 
prevalent in Southern Europe, Japan and USA, it is not observed in countries 
with the highest HCV prevalence suggesting that other factors than HCV 
infection alone mediates the observed association with OLP. In OLP, HCV 
replication has been reported in the epithelial cells from the LP lesions by 
reverse transcription/polymerase chain reaction and by in-situ hybridization. 
Moreover, HCV-specific CD4 and CD8 lymphocytes could be isolated from the 
subepithelial band. This may either suggest that HCV-specific T lymphocytes 
participate in the immunopathogenesis of OLP, or that the lesion attract memory 
T cells in a non-specific manner (by standing phenomenon). Whether HCV 
infected patients have increased risk of developing OLP or patients with OLP 
have enhanced risk of developing HCV infection is yet to be answered (26) 
Studies show that patients with hepatitis C virus have a higher prevalence of 
OLP than control groups (2). However this apparent connection may be 
explained by differences in the incidence of Hepatitis C infection (23). 
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Differential diagnosis and lichenoid reactions (LR) 
Differential diagnosis include, lupus erythematous, leukoplakia, erytroleuko-
plakia, white sponge nevus, candidiasis, proliferative verrucous and leukoplakia 
(18).  
 
Graft vs. Host disease (GVHD) is a common serious complication following 
allogeneic tissue transplant. Oral involvement occurs in 33% to 75% of patients 
with acute GVHD and up to 80% of patients with chronic GVHD (3). Oral 
mucosal GVHD resembles OLP both clinically and histologically.  
 
 
 
Oral mucosal lichenoid lesions may also develop after systemic drug 
administration. Lichenoid drug reactions (LDR) may be unilateral but usually 
appear bilateral, similar as idiopathic OLP. Drugs that have been implicated in 
oral LDR include NSAIDs, ACE inhibitors and beta-blockers.  
 
Oral mucosal lichenoid lesions (LR) may be seen in close contact with dental 
restoration or provision of a denture. These lichenoid reactions are usually the 
result of a contact sensitivity or irritant contact response (Type 4 immune 
reaction) to an amalgam or composite resin dental restoration or a denture 
component in close proximity to the oral mucosa (3).  
 
Lichenoid reactions (LR) should, by definition, resolve after the causing agent(s) 
are removed.  
 
 
Figure 10: Lichenoid 
reaction on the buccal 
mucosa in a patient with 
graft vs host disease. 
From www.ispub.com 
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Traditionally Both CD8+ and CD4+ effector T lymphocytes, including Th1, Th2 
and Th17 are thought to be the predominant cell types in OLP (5).  We observed 
(Koren et al, IOB seminar 2005), that regulatory T-cells (CD4+CD25+FoxP3+  
Treg) make up a large part of the lymphocyte infiltration in OLP, an observation 
confirmed by others (10). Thus the modulating role of Tregs in this chronic 
condition has become a focus of research interest (10).   
T cell maturation is regulated by professional dendritic cells (DC) which play an 
important role in initiating and controlling the immunologic activity of this 
disease (6,7). But even the DC needs to be differentiated in order to function as 
immune regulators.  
In 2008 Singh et al., reported that a self peptide derived from ApoE  had the 
ability to differentiate  murine and human monocytes to become dendritic cells 
which functioned as immune modulators and suppressed inflammation (5).  
By using global gene expression studies (microarray) of OLP lesions we had 
revealed that ApoE was 8-12 times more expressed in diseased OLP mucosa 
compared to none, or less diseased areas.  
Thus, could increased ApoE expression explain some of the immune regulatory 
phenotypes observed in OLP?  
Figure 9: Licheniod 
reaction (LR) on buccal 
mucosa. Hypersensitivity 
reaction to amalgam (type 
IV immune reaction). 
Removal of amalgam 
usually leads to healing of 
the lesion.  
From: www.hindawi.com. 
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Background and Theory 
 
Dendritic Cells are professional antigen presenting cells (APC). They can 
induce, sustain and modulate immune responses in humans (14). DC’s engulf, 
process and present antigens on MHC-II molecules to different subsets of CD4+ 
T-helper cells (see figure 1). Dendritic cells have a modulating effect on 
cytotoxic CD8+ T lymphocytes and B cells among others (14). DC’s of 
lymphoid and myeloid origin are found in both humans and mice 
 
 
Figure 11: Immune regulation via Dendritic Cells (11). Th17 has mostly extracellular 
functions. Th1 cells are predominantly against intracellular virus and bacteria. Th2 is 
primarily effective against parasites and is connected to Eosinophilic reactions. The main role 
of Treg is suppression of inflammation. 
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T lymphocytes are cells of the lymphoid pathway that mature in thymus. They 
play a vital role in the cell-mediated immune system. All T cells express T cell 
receptor (TCR) on the surface. Several different types of T cells exist, including 
CD4+ T-helper cells (Th17, Th1, Th2 and Treg), CD8+ cytotoxic T-cells, T 
memory cells, regulatory T-cells (Tregs) and natural killer T cells (NKT).   
Tregs are a subpopulation of T cells. They have properties that enable them to 
modulate immune responses. The most known of these cells are CD4+ T cells 
that co-express CD25 and Foxp3 (CD4+CD25Foxp3+ T cells) (5, 16). CD25 is 
the alpha chain of the IL-2 receptor for IL-2.  There are two major types of 
CD4+CD25+ T-cells. Natural occurring Treg (nTreg) derive from the thymus 
whereas peripherally induced Tregs are named: iTreg (16). Foxp3 is a 
transcription factor and serves as a master regulator of the function and 
development of CD4+CD25+ regulatory T cells (10, 16). Mutations in the 
Foxp3 gene results in loss of function for both nTreg and iTreg (16).  Many of 
the intra- and sub-epithelial T cells in OLP, express Foxp3 and CD25+ (10). 
This suggests that Treg play a key role in regulating the complex immune 
reaction in OLP. DC-induced Treg division requires IL-2. This is mediated by 
conventional CD4+ T cells via MHC-II interactions (20). 
ApoE: Apolipoprotein E is a class of lipoprotein that has an important role in the 
metabolism of lipids. It is found in chylomicrons and on LDLs  (low density 
lipoproteins). ApoE is synthesized and secreted by many tissues, primarily liver, 
brain, skin, and tissue macrophages throughout the body.  In addition to the well 
established role as a lipid transport protein, ApoE has also a modulating function 
in immune responses with the ability to either inhibit or stimulate antigen- and 
mitogen-induced T lymphocyte activation and proliferation (9, 12). 
ApoE is located on chromosome 19, along with ApoC1 and ApoC2. It consists 
of 284 base pairs, with 3 different isoforms: ApoE2, ApoE3 and ApoE4 (13). 
E2 is associated with hyperlipidemia type III, E3 is the most common and thus 
considered the normal variant and E4 is associated with increased risk of 
atherosclerosis and Alzheimer’s disease.   ApoE has also been attributed to 
immune regulation  (9). 
The allelic forms differ from each other only by amino acid substitutions at 
positions 112 and 158. [7] The E2 allele has a Cys at positions 112 and 158 in 
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the receptor-binding region of ApoE. The E3 allele is Cys-112 and Arg-158. The 
ApoE E4 allele is Arg at both positions (9,13) 
Macrophages are among the cells that express high levels of ApoE (14). 
Production takes place in brain, spleen, liver, kidney, and muscle tissue (21). 
 
Theory:  
Macrophage production of ApoE may stimulate dendritic cells to become 
tolerogenic. Leading to a potent stimulation of different subsets of T-
lymphocytes and thus induce local Treg differentiation. 
 
Materials and methods 
 
Microarray 
Microarray is a collection of microscopic DNA spots attached to a solid surface 
(e.g. glass or silicon chip). DNA microarray is used to measure the expression 
levels of large numbers of genes in one test. Each DNA spot contains a specific 
DNA sequence, known as probes. These can be a short section of a gene or other 
DNA. Probe-target hybridization is usually detected and quantified by to 
determine relative abundance of nucleic acid sequences, and thus the gene 
expression profile, in the target tissue. 
An array contains thousands of these DNA sequences. This makes it possible to 
perform many genetic tests at the same time. 
DNA microarrays can be used to measure changes in gene expression levels, 
detection of single nucleotide polymorphisms (SNPs), or to genotype any 
targeted sequence. 
The core principle of microarray is hybridization between two DNA strands. 
Complementary nucleic acid sequences pair with each other by forming 
hydrogen bonds between complementary nucleotide base pairs. After washing 
off of non-specific bonding sequences, only strongly paired strands will remain 
hybridized.  
17 
 
Fluorescently labeled target sequences that bind to a probe sequence generate a 
signal that depends on the hybridization conditions (such as temperature), and 
washing after hybridization. Total strength of the signal, from a spot (feature), 
depends upon the amount of target sample binding to the probes present on that 
spot.  
Microarrays use relative quantification in which the intensity of a feature is 
compared to the intensity of the same feature under a different condition, and the 
identity of the feature is known by its position. This makes it possible to 
compare sick and healthy tissue. 
Two-color microarrays or two-channel microarrays are typically hybridized with 
cDNA prepared from two samples to be compared (e.g. diseased tissue versus 
healthy tissue) and that are labeled with two different fluorophores (17). This 
technique was used in our study. 
Fluorescent dyes commonly used for cDNA labeling include Cy3, which has a 
fluorescence emission wavelength of 570 nm (corresponding to the green part of 
the light spectrum), and Cy5 with a fluorescence emission wavelength of 670 
nm (corresponding to the red part of the light spectrum).  
The two Cy-labeled cDNA samples are mixed and hybridized to a single 
microarray that is then scanned in a microarray scanner to visualize fluorescence 
of the two fluorophores after excitation with a laser beam of a defined 
wavelength (see figure 3 and 4).  Relative intensities of each fluorophore may 
then be used in ratio-based analysis to identify up-regulated and down-regulated 
genes (18). 
Biopsies from two patients (LR33 and LR34) were stored on RNAlater (SIGMA 
R0901) to prevent RNA degradation of biological material subject to RNA 
extraction. Samples stored in RNAlater RNA Stabilization Reagent stabilize and 
protect cellular RNA from 1 day (37C) to 4 weeks (2-8C) (22). 
These biopsies were later used for Microarray study, RT-PCR and IHC. 
RNA was extracted with RNeasy Mini Kit (Qiagen cat. 74104) (column based 
RNA extraction). 
DNA Array 900 Cy3™/Cy5™ Kit ( Genisphere cat. W500180) was used to 
make labeled cDNA with fluorescent dyes.  
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Cy-3/Cy-5 labeled cDNA was hybridized to micro array slides in a 
“Slidebooster” (Advalytix). This ensures correct temperature, moisture and 
mixing during hybridization.  
Slides scanned in “ScanArray Lite” (Packard Bioscience). 
The results were processed in J-express.  
 
 
Figure 12: Microarray Detection with 3DNA Reagents (17) 
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Figure 13: RNA extracted from biopsy is processed with microarray. Results revealed that 
ApoE was 8-14 times more expressed in tissue with high degree of inflammation compared to 
areas with lower degree of inflammation in the same patient. Results were confirmed with Rt-
PCR. This gave a basis for further studies. Tissue samples taken from the same patients were 
tested with immunohistochemistry.  
 
Microarray 
 
Up regulated genes verified with RT-PCR. 
ApoE selected for investigation. 
 
ICH on tissue samples from OLP patients. 
ApoE in the epithelium  
Furter testing: 
PCR 
Cellcultures 
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Figure 14: Microarray results showing high levels of ApoE expressed in OLP tissue indicated 
by the intense green spot (arrow). 
 
Real Time Polymerase Chain Reaction 
Real-time polymerase chain reaction is a method used for amplification and 
quantification of a targeted DNA molecule. The procedure follows the general 
principle of polymerase chain reaction (PCR). The amount of amplified DNA is 
detected in real time. 
Two common methods for detection of products in real-time PCR are: (1) non-
specific fluorescent dyes that intercalate with any double-stranded DNA, and (2) 
sequence-specific DNA probes consisting of oligonucleotides that are labeled 
with a fluorescent reporter which permits detection only after hybridization of 
the probe with its complementary DNA target. 
Real-time PCR can be combined with reverse transcription to quantify mRNA 
and non-coding RNA in cells or tissues. 
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A DNA-binding dye binds to all double-stranded (ds) DNA in PCR, causing 
fluorescence of the dye. An increase in DNA product during PCR therefore 
leads to an increase in fluorescence intensity and is measured at each cycle. This 
allows DNA concentrations to be quantified.  
In our study CDNA was synthesized with Revert Aid H Minus First Strand 
cDNA Synthesis Kit (Fermentas cat. 1631). Using RealMasterMix (Qiagen cat. 
0032 002.492) PCR machine MX 3005P (Agilent). 
The following primer sequences were used in our study for RT-PCR: 
APOE Forward primer:   CTGCTCAGCTCCCAGGTC 
APOE Reverse primer:    TTGTTCCTCCAGTTCCGATT 
 
 
Figure 15: RT-Pcr dissociation curve. Also known as melting curve analysis. Show the 
temperature where 50% of DNA strands separate into single strands. It is used to determine the 
purity of the amplification.  Diagram with one clear peak as shown above indicates amplification 
without non-specific products or contamination. In addition gel electrophoresis was performed on 
the PCR to confirm the specificity of the primers. 
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Figure 17: Amplification plots. 
X-axis show number of cycles. Y-axis show 
fluorescence intensity (SYBR Green).  
Gene of interest ApoE from 6 samples. 
Samples with highest level of ApoE 
furthest to the left and lowest level to the 
right. 
Figure 16: Thermal profile. Temperature 
changes in the Rt-PCR machine. 
Segment 1: denaturation of DNA. 
Segment 2: amplification cycles with 
denaturation, annealing (primer 
binding) and extension. Cycle repeated 
40 times. Segment 3: Dissociation 
curve to determine the purity of the 
product.  
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Immunohistochemistry (IHC) 
Immunohistochemistry is the process of detecting antigens in cells of a tissue. 
The principle of this method is antibodies binding specifically to antigens in a 
specific biological tissue. 
Visualizing an antibody-antigen interaction can be accomplished in different 
ways.  Usually an antibody is conjugated to an enzyme, such as peroxidase, that 
can catalyze a color-producing reaction (see figure 5). 
Alternatively, the antibody can also be tagged to a fluorophore, e.g. fluorescein 
or rhodamine. 
The antibodies used can be polyclonal or monoclonal. Polyclonal antibodies are 
made by injecting animals with peptide Ag.  A secondary immune response is 
stimulated and finally antibodies are isolated from whole serum. Polyclonal 
antibodies are a heterogeneous mix of antibodies that recognize several epitopes. 
Monoclonal antibodies show specificity for a single epitope and are therefore 
more specific to the target antigen than polyclonal antibodies. 
Antibodies used in IHC testing are classified as primary or secondary reagents. 
Primary antibodies are raised against an antigen of interest and are typically 
unconjugated (unlabeled). Secondary antibodies are raised against immune-
globulins of the primary antibody species. The secondary antibody is usually 
conjugated to a linker molecule (Figure 12).  
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Figure 18: Primary and secondary antibody (18). Primary antibody binds to antigen epitop. Secondary 
antibody binds to a seat on the primary antibody. Secondary antibody is marked with fluorescent 
material making it possible to visualize. 
 
Antigen Producer Host Isotype 
CD68, macrophage Dako Mouse IgG1 
HLA-DR DB Biosciences Mouse IgG2a 
CD86, B7-2 R&D Mouse IgG1 
CD209 (DC-SIGN) Beckman Coulter Mouse IgG1 
Apolipoprotein E Abcam Rabbit - 
DEC-205/CD-205 R&D Goat IgG 
Figure 19: List of antibodies used in our study. 
 
“Axioplan 2” (Zeiss) fluorescence microscope was used for IHC analyses.  
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Cell culture 
The two human monocytic cell lines THP-1 and U-937 were cultured in RPMI 
1640 with 10% FCS (Fetal Calf Serum).  
Immunofluorescence staining was also performed after cytospin on stimulated 
THP1 and U937 cell lines (Ap1.B). The negative humanized control peptide was 
similar as the active humanized peptide but alanine was substituted for 
phenylalanine in position 11, called hEp1.N .  
1 million cells were grown in 1ml culture media in a 24 well culture plate, 
stimulated with peptides for 24 and 48 hours prior to RNA extraction. Cytospin 
was performed because the cellular “clumping” made flowcytometric analysis 
impossible.  These cells were then subjected to IHC analysis.  
Cell culture setup used in our study: 
13 : Negative control, cell line U937 (no peptide) for 24 hrs 
14: Cell line U937 incubated with humanized peptide hEp1.B  for 24 hrs 
15: Cell line U937 incubated with the humanized control peptide hEp1.N for 24 hrs 
16:  Negative control, cell line THP-1 incubated without peptide for 24 hours 
17:  Cell line THP-1 incubated with the humanized peptide hEp1.B for 24 hours 
18:  Cell line THP-1 incubated with the humanized control peptide hEp1.N for  24 hours 
19:  Cell line THP-1 incubated with the humanized peptide hEp1.B for 48 hours 
20: color control 
 
Flow cytometri was not performed because of the precipitation. Lack of single 
cells made it impossible to run flow cytometri. 
To make a human analogue of Ep1.B, two amino acids were replaced. The 
peptide was synthesized by Thermo Fisher Scientific.  
Human Ep1.B sequence (hEp1.B): AQQIRLQAEAFQAR.  
Negative humanized control peptide hEp1.N sequence: AQQIRLQAEAAQAR.  
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Biopsies stored on 
RNA-later 
RNA extraction Transferred to 
1,25% TLP 
20% sucrose 
Assembled in 
OCT and frozen 
Frozen samples 
cut in 5 µm thick 
sections 
IHC HE 
cDNA with 
poly dT 
cDNA with 
3DNA marked 
poly dT 
PCR Micro 
array 
Figure 20: Flowchart of the processing of biopsies. 
Collected tissue samples stores on RNA-later 
divided in two groups. Material for PCR  is 
converted to cDNA with poly dT before PCR. 
Material for micro array is converted to cDNA and 
attached with 3DNA marked poly dT.  Biopsies 
samples for immunohistochemistry  (ICH)and HE  
were first transferred to 1,25% TLP fixative for 
four hours, then in 20% sucrose solution for 30min 
before assembled in OCT, frozen and then cut in 5 
µm thick sections before ICH and HE testing could 
proceed. 
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Results 
Previous work at our laboratory has shown an increase in regulatory T-
lymphocytes in oral lichen planus (OLP) (10).  
mRNA for ApoE is upregulated in OLP. 
Preliminary IHC coloring showed that ApoE was present in the epithelium of 
both patients.  
Microarray done on biopsies from 2 patients with OLP showed an increase of 
ApoE in sick tissue compared to tissue with less degree of inflammation in the 
same patients. Expression levels of ApoE were up regulated 8,8 times in sick 
tissue compared to tissue taken outside the lesion in  patient LR33. In patient 
LR34 the expression level was increased over 14 times (figure 21). Even though 
this is a low number of patients, the results were consistent and gave us a basis 
for further investigation. 
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Figure 21: Micro array analysis of ApoE showing increased expression levels in lesions with 
oral lichen planus compared to control tissue. In patient LR33 the level of ApoE was 
increased 8.2 times. In patient LR34 the level was increased 14.31 times.  
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Real time PCR showed that ApoE was up regulated in OLP, confirming the 
previous results from our micro array. The results from PCR and micro array 
were very consistent. 
    
      
      
 
Figure 22: Real-time PCR analysis showing difference in levels of ApoE between tissue with 
low degree of and inflammation and tissue taken from area with high degree of inflammation 
in 2 patients. In patient LR33 the expression levels of ApoE was increased by 8.2 times in 
sick tissue. In LR34 the expression level was increased 14.32 times. This confirmed our 
microarray findings. 
 
Biopsies from seven OLP-patients were cut in smaller pieces before RNA-
extraction. APOE and CD3 expression where quantitated by real-time PCR. The 
CD3 expression where used as a measure of the density of the infiltrate.  APOE 
mRNA where up-regulated in areas with denser infiltrate (Figure 23) 
The three outliers with very high APOE expression were samples with low RNA 
yield and lower alpha-tubulin expression, suggesting that these were parts of the 
biopsies containing adipose tissue. 
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Figure 23:  Real-time PCR on biopsies from 7 patients shows higher expression of APOE in 
areas with denser infiltrate (higher CD3).  
hEp1B precipitate in culture media 
The peptide was first added to the culture medium at a concentration of 200 
µg/ml and vortexed. The peptide was in solution before adding 500 µl of cells. 
After some time, the peptide precipitated in the culture media. The same 
happened in media alone, both in serum free medium, and in medium 
supplemented with calf serum. The peptide precipitated in the serum-
supplemented medium, only. 
When changing the peptide to a human analog of the murine peptide, The two 
amino acids which were replaced in order to humanize the peptide, replaced one 
hydrophilic with a hydrophobic amino acids increasing the number of 
hydrophobic residues from 47 % to 50 %. 50% hydrophobic residues are about 
the limit for a water soluble peptide.  However, the control peptide had similar  
50% hydrophobic residues without any precipitating properties, arguing against 
this as the sole explanation for the observed precipitating. 
hEp1B peptide induced cell aggregation but not DC-like morphology 
Both U937 and THP-1 grow as semiadherent cells. When stimulated with the 
hEp1B peptide, first the adherent cells started to detach in sheets after 30 
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minutes, and then later on the cells aggregated in clusters. No dendritic 
morphology was seen. 
Dendritic cells in Oral Lichen Planus 
IHC was performed on biopsy tissue from OLP.  Samples from small intestine 
and palatine tonsils were used for controls.  Double staining was performed on 
all samples.  
We used dendritic cell markers DEC-205 (CD205), CD11c, CD103, CD19, as 
well as Garp, ApoE, Foxp3 and LAR (se antibody list). DEC-205 is a cell 
surface receptor for CpG oligonucleotides. Primarily expressed on DCs, but also 
expressed on B cells, T cells and thymic epithelial cells. It is significantly up 
regulated in mature DCs. It plays an important role in uptake of extracellular 
proteins, which then are processed internally and subsequently presented on 
HLA class-II molecules. 
The epithelium had a homogenous increased staining for ApoE, which was 
difficult to discriminate from background staining. There were many ApoE+ 
cells in the sub epithelial infiltrate, but none of these co-expressed CD11c or 
CD205 (DEC205). 
This was in contrast to tonsillar tissue where almost all ApoE+ macrophages co-
expressed CD11c+ cell, particularly in the germinal centers (tingle body 
macrophages).  
DEC 205 was expressed by the basal keratinocytes particularly in less inflamed 
areas.  Many DEC-205+ macrophage/dendritic cells were observed in the deeper 
subepithelial area, whereas CD11c + cells were located in the lamina propria.  
DEC-205 was translocated in peptide stimulated cell cultures. 
U937 cells stimulated in culture for 24 hours without peptide was weak CD11c+ 
and DEC205+, a few cells (~1%) were CD86+, none were DC Lamp+. 
Stimulating U937 cells with the active peptide hEp1.B for 24 hours revealed no 
increased expression of CD11c or DEC-205 compared to cells stimulated with 
the negative peptide, hEp1.N.  THP-1 cells stimulated without peptide for 24 
hours showed weak DC Lamp positivity but no DEC-205 expression. However, 
the majority of the cells were DEC-205+ when stimulated with hEp1.B for 24 
hours, in contrast to those stimulated with the negative peptide hEp1.N, 
confirming the apparent up regulation of DEC-205 on the THP-1 cells. However 
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the humanized Ep1.B precipitated and induced cell aggregation, which may 
have activated the cells. Why this happened is not clear.  
 
Discussion 
Oral lichen planus is dominated by an intense mononuclear leukocyte infiltration 
composing of T cells and macrophages. We previously observed that 40% of the 
CD4+ T cells coexpressed Foxp3+, similar to regulatory T cells (Tregs). Thus 
these regulatory cells may control the intensity of the inflammation in OLP.  By 
microarray based gene expression screening, we observed a peculiar strong 
mRNA increase for lipoprotein ApoE in OLP.  ApoE belongs to a family of 
lipoproteins which predominantly have been implemented in fat metabolism. 
However in 2008 Singh et al. reported that a self-peptide derived from 
Apolipoprotein E stimulated monocytes to become dendritic cells with 
immunmodulating properties. Although Singh et al., used a murine derived self-
peptide sequence and showed that the murine monocyte cell line (PU5-1.8) were 
stimulated to become dendritic cells, it also worked on the  human  monocyte 
cell line (U937) (5). The self-peptide, Ep1.B, down regulated T cell proliferation 
and IFN-y production and stimulated IL-10 secretion in immunized mice. Thus, 
it functioned as an immune regulator and suppressed the inflammatory process. 
Singh et al., observed, moreover, that the Ep1.B peptide induced the monocyte 
cell lines to up regulate the DC-specific markers CD83, CD80 /CD86, CD11c 
and DEC-205. 
The receptor for this self-peptide was not identified, but Toll like receptor 4 (the 
LPS receptor) and MHC-class II were excluded.  The authors did not discuss 
how the murine self-peptide could exert its effect on human cells, as surface 
receptors do not tend to be so well conserved.  The human version of this 
peptide differs with 2 amino acids, so we decided to use the human homolog for 
the self-peptide to stimulate human monocyte cell lines. Shifting the two amino 
acids from murine sequence to human sequence made the peptide somewhat less 
hydrophilic. Adding the humanized, active hEp1.B peptide to the culture media 
resulted in strong precipitation reactions, apparently making salt bridges as the 
precipitate was far bigger than could be explained by the concentration of the 
peptide alone (0.2 % solution). Moreover, the cells became attached to each 
other and formed large clusters which could not be resolved. This was only 
visible with the humanized hEp1.B peptide and not with the humanized control 
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peptide, which had similar hydrophilic properties. The cell clusters stayed 
together for more than 48 hours and made it impossible to perform 
flowcytometric analysis on stimulated cells. Thus we were forced to perform 
cytospin based immunofluorescence examination of the stimulated cells, instead 
of flow cytometric analysis which would have been preferable  
The precipitation reaction was a surprise and made us wonder whether the 
concentration of the peptide was too high. However, Singh et al., used the 
peptide in 100 µg/ml peptide, which equals 61,3 µM (µmol/liter) which equals a 
0,2% solution of the whole ApoE protein. This may not be too far from the local 
concentration during peptide release. However the reactions points to a possible 
non-specific protein-peptide-salt interaction as revealed by the strong 
precipitating reaction observed in both serum containing and serum free cell 
culture media.  
Such non-specific protein-binding properties may also explain the induction of 
monocytes to dendritic cells in the murine system as the morphological changes 
was observed after 10 min (8).  The peptide mimics, in this respect, the 
activation properties that lectins have on T cell activation.  
We did not use the murine peptide. It is, therefore, unknown whether the 
precipitating effect of the humanized peptide was specific, or whether it also 
appeared with the murine peptide. The control peptide did not precipitate. 
Moreover, we performed several dilution experiments to prevent the 
precipitations, but none were successful. This reaction needs, however, clearly 
further investigation.  
The peptide induced, nevertheless, increased expression of  DEC-205 on the 
THP-1 cells, but not on the human U937 cells Singh et al., used. The 
immunofluorescence staining on the stimulated cells showed an increased 
surface expression of DEC-205, suggesting an increased translocation of 
intracellular DEC-205 after peptide stimulation. DEC-205 is known to be stored 
intracellular and may be translocated to the surface upon activation. This would 
explain Singh et al, results. However, we cannot explain why the U937 cells did 
not respond on the humanized hEp1.B peptide, in contrast to what Singh et al 
reported with the murine peptide. If similar self peptides derived from ApoE has 
similar effect on human monocytes it must be the human peptide sequence that 
matter. However, as long as we have not isolated the human self peptide, it 
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cannot be excluded that similar phenomenon exists in the human system, but 
that the self peptide is derived from other part of human ApoE. Only further 
studies may reveal whether such self peptides exist in human and whether these 
self-peptides has similar immunomodulation effect on human cells as reported 
by Sing et al. 
Conclusion 
Our study showed that Apolipoprotein (ApoE) is up regulated in oral lichen 
planus. It is however unclear if this up regulation play a role in the 
differentiation of monocytic cell lines to functional dendritic cells. Only 
membrane expression of CD205 was increased on THP-1 after incubation with 
the humanized hEp.1B.  However, the humanized peptide precipitated in the cell 
culture media and induced cell adherence, which was not reported when the 
murine version of the self peptide was used. However one need to do the exact 
same setup as Singh et al., used to examine if this response is selective for the 
humanized hEp.1B  peptide.   
ApoE is nevertheless increased in oral lichen planus, but our data do not support 
that self peptides from ApoE induce monocytes to differentiate into tolerogenic 
dendritic cells involved in the increased lesional density of Tregs in OLP. 
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